Apexus Announces $2 Millon Shareback Program
For Eligible Participants
Contact:
Kathryn Goldstein
Dir of PR, Apexus
Kgoldste340b@340bpvp.com
972.581.5529
IRVING,
TX (Nov. 14, 2008) - Apexus,
Inc., the Health Resources and Services
Administration’s (HRSA) awarded
prime vendor for the 340B Program (PVP),
announced today its Board of Directors
has authorized a shareback program for
eligible participants. Nearly 1000 participants
will benefit from $2 million dollars in
shareback funds. The recipients will receive
the Apexus shareback in the form of a
wholesaler credit to their respective
340B accounts during the week of November
17.
“Apexus is dedicated to bringing
the Prime Vendor Program participants
unmatched savings and value. This shareback
program reinforces our commitment to these
organizations,” said Chris Hatwig,
M.S., R.Ph. FASHP, vice president, 340B
Prime Vendor Program/Apexus. “HRSA
was very supportive of the proposed shareback
strategy as a means of further reducing
medication costs for the program’s
most active participant who are committed
to improving access to affordable medication
for their patients.”
# # #
Apexus Inc.,
Founded in 2007, Apexus Inc., a nonprofit
corporation, is the HRSA’s Office
of Pharmacy Affairs awarded contractor
to serve as the prime vendor for the 340B
Program. Based in Irving, Texas, the prime
vendor’s role is to secure discounts
on 340B outpatient drug purchases and
other pharmacy related products and services
for participating public hospitals, community
health centers, and other safety-net health
care providers electing to join the program.
For
more information on Apexus.
|
